| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |